As of Mar 05
| +1.12 / +2.94%|
The 5 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 42.00, with a high estimate of 50.00 and a low estimate of 33.00. The median estimate represents a +6.98% increase from the last price of 39.26.
The current consensus among 8 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.